RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

Not a good sign of what?

We know that there are no leaks from the SA trial--if there were, the share price would have been declining before the ASM. And there is no such thing as a negative leak when it comes to partnering/M&A--even if one company's source said 'we're not interested', that says nothing about the others.

In the absence of predictable news (because now we have no idea what will transpire with the SA trial, or when), I think the disappointment over the trial progress is a pretty good reason for downward drift. Plus, we have no way of knowing how completely the group that did the funding has wound down their position--my guess is most of it has been, but it could trickle for a while.

NeuroInvestment